Aarti Pharmalabs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
AARTIPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarti Pharmalabs Limited has submitted a certificate to the stock exchange as required under the SEBI (Depositories and Participants) Regulations, 2018. Such filings are typically routine compliance submissions related to the company's shares in dematerialised (demat) form, often covering reconciliation of share capital or confirmation that all share certificates have been converted into electronic form. The announcement does not include any financial numbers, business update, or corporate action. It is a procedural disclosure made to maintain regulatory compliance with depository norms.
This is a routine regulatory filing with no material impact on the company's operations, financials, or stock price. Shareholders need not take any action — it simply confirms ongoing compliance with SEBI's depository regulations.